Pfizer (PFE) reports combined effects for the third quarter of 2023 and reaffirms its 2023 sales and earnings guidance earlier this month.
Pfizer (PFE) third-quarter losses narrow, missing due to COVID crash Read More »
A report published in the Journal of Applied Laboratory Medicine through the Association for Diagnostics
A video shared by Elon Musk collects screenshots of headlines that appear to show a drop in estimates of protection against Covid-19 vaccines. The clip lacks context; The headlines are presented in no particular order, unparalleled data, and while vaccines don’t fully protect against infection, doctors and epidemiologists say they’re effective at reducing the risk of severe illness and death.
Musk Shares Misleading Article About Covid-19 Vaccine Efficacy Read More »
(Bloomberg) — From small restaurants to high-tech corporations to a fuel plant run by Chevron Corp. , Israeli businesses are being rocked by the war against Hamas. SyriaInnovation and anti-obesity drug Lilly pushes for further weight loss in trial Saudi forces on alert after fatal clash with Houthi rebels Israel-Hamas escalation of war tests Qatar’s influence Sony’s Bungie gaming unit cuts back after title delayMa
Israel’s effort is giving its economy a Covid-like shock Read More »
Pathize Health has announced a new app to help people with chronic Covid monitor their energy levels throughout the day using biometrics.
Pathize App Uses Biometrics for Long Covid Patients to Manage Fatigue Read More »
Designed for Patients Immunocompromised by Severe COVID-19 ATLANTA, GA, October 30, 2023 (GLOBE NEWSWIRE) – via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company that is developing immunotherapies and vaccines for cancer and infectious diseases, today announced that it has begun planned site expansion for the Phase 2 clinical trial of its next-generation SARS-CoV-2 vaccine, GEO-CM04S1, as the number one vaccine in immunocompromised patients.
GeoVax Begins Site Expansion for Phase 2 Trial of Next-Generation COVID-19 Vaccine Read More »
In Los Angeles and elsewhere, some parents are struggling to find the new pediatric COVID vaccine, especially for children under 5. Not all pediatricians or pharmacies have it, even if vacunas. gov say so.
As winter approaches, some parents are still in favor of the new pediatric COVID vaccine Read More »
Reducing serotonin levels may be just the first step in losing light on the causes and possible remedies for long Covid.
Why New Serotonin Research Could Be a Game Changer During Long Covid Read More »
For centuries, we’ve known that some viral infections peak in the winter months, but why is there seasonality associated with certain diseases?
‘Tis the Season: Why Flu and Covid-19 Rise in Winter Read More »
Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that the Nuvaxovid™ XBB. 1. 5 injectable dispersion of COVID-19 vaccine (recombinant, adjuvanted) (NVX-CoV2601) has been approved for active immunization to save COVID-19 caused by SARS-CoV-2 in Americans aged 12 years and older in the European Union through the European Union’s Committee for Medicinal Products for Human Use (CHMP). Medicines Agency. European Communications
